Consumer Research
Yale Budget Lab Outlines Multibillion Dollar Future for Federal Cannabis
NEW HAVEN – The fiscal argument for federal Cannabis legalization ...
Delaware Moves to Regulate THC-Infused Beverages
DOVER – Delaware's Senate Banking, Business, Insurance & Technology Committee ...
AMASS Invests in Hemp-Derived THC Beverage Brand Afterdream
LOS ANGELES – AMASS Brands Group, a California-based multi-category beverage ...
Safe Harbor Targets Retirement Gap in Cannabis Workforce
DENVER – Safe Harbor Financial is extending its reach deeper into workforce benefits, introducing a pooled employer 401(k) plan designed for Cannabis operators that have long struggled to access conventional retirement services. The new offering, ...
AtaiBeckley Reports Expanded Phase 2a Data for EMP-01 in Social Anxiety Disorder
NEW YORK – AtaiBeckley Inc., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, released additional results from its exploratory Phase 2a trial of EMP-01, an oral formulation ...
Industrial Hemp Market to Exceed $7B by 2031, Driven by Construction and Wellness
LOS ANGELES – The global industrial hemp market is on track to nearly double in value over the next five years, according to the latest report by Mordor Intelligence that projects the market to grow ...
TerrAscend Reports Q4 and FY 2025 Financial Results
TORONTO – In an industry still wrestling with persistent pricing compression, TerrAscend Corp. managed to hold the line on profitability while posting modest sequential growth in its latest quarter. The company released its financial results, ...
Michigan Cannabis Sales Hit $3.17B in 2025, First Annual Decline Since Legalization
LANSING – Michigan consumers purchased $3.17 billion in recreational Cannabis products in 2025, the Cannabis Regulatory Agency (CRA) reported, marking the first year-over-year drop in total sales revenue since the state began adult-use retail operations ...
MariMed Reports Q4 and FY 2025 Financial Results
NORWOOD – MariMed Inc. released its fourth-quarter and full-year 2025 financial results, reporting a modest revenue increase that reflects the company’s focus on branded wholesale gains in an environment of sustained margin compression across multiple ...
Verano Reports Q4 and FY 2025 Financial Results
CHICAGO – Verano Holdings Corp. released its financial results for the fourth quarter and full year ended December 31, 2025, showing sequential revenue growth and improved gross margins in the final three months but a ...
President Trump Signs EO to Accelerate Psychedelic Research and Access
WASHINGTON – President Donald Trump signed an executive order directing federal agencies to speed up reviews of certain psychedelic compounds and open new pathways for patient access as treatments for serious mental health disorders like ...
Trump Fast Tracks Psychedelic Research
WASHINGTON D.C- President Donald Trump has signed a sweeping executive order to accelerate psychedelic research and expand patient access across the United States—marking one of the most significant federal policy shifts the sector has seen ...
Decibel Reports Q4 and FY 2025 Financial Results
CALGARY – Decibel Cannabis Company Inc. posted audited results for the fourth quarter and full year ended December 31, 2025, showing overall revenue growth driven largely by its international operations. Net revenue for the year ...
University of Utah Launches Medical Cannabis Research Center
LOS ANGELES- The University of Utah is taking a significant step forward in the realm of medical cannabis research with the establishment of the Center for Medical Cannabis Research (CMCR). Announced on November 21, this ...
Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results
LOS ANGELES- Numinus Wellness Inc. has announced its financial results for the fourth quarter and the full year of fiscal 2023, highlighting significant revenue growth and strategic advancements in its operations. Fourth Quarter Fiscal 2023 ...
New York Cannabis Control Board Approves Settlement
NEW YORK- In a pivotal decision this week, the New York Cannabis Control Board resolved a lawsuit brought by military veterans, unlocking the way for over 400 adult-use cannabis dispensaries to progress in the state. ...
California and Michigan Boost Social Equity in Cannabis Industry with New Funding Initiatives
LOS ANGELES- In a significant move to bolster social equity within the cannabis industry, both California and Michigan have recently taken steps to channel more funding into social equity cannabis companies. California is set to ...
Clearmind Medicine Inc Reports Promising Results in Pre-Clinical Trial for Combination Therapy
LOS ANGELES- Clearmind Medicine Inc has announced the results of its pre-clinical trial involving a combination therapy, marking a significant step in the development of treatments for addictions, obesity, metabolic disorders, and depression. The trial ...
RIV Capital’s Ambitious Transition to Adult-Use Cannabis Sales in New York
LOS ANGELES- RIV Capital, a Toronto-based cannabis investment firm, has navigated a turbulent path in its growth story, particularly in the New York market. Initially setting up as one of the few medical cannabis operators ...
Health Canada Approves Jazz Pharmaceuticals’ Epidiolex
NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a supplementary therapy for certain rare and severe forms of ...
Record Sales on Green Wednesday Signal Booming Cannabis Market
LOS ANGELES- The cannabis industry experienced a significant surge in sales on Green Wednesday, the day before Thanksgiving, marking it as a high-point in annual cannabis commerce. Jane Technologies reported recreational cannabis sales totaling an ...
Arkansas and Rhode Island Cannabis Markets
LOS ANGELES- October 2023 witnessed a modest reduction in medical cannabis sales in Arkansas, reaching $22.5 million, a slight decrease from the same period in 2022. This data, sourced from the state's Department of Finance ...
Wisconsin Legislators Advocate for Veterans’ Access to Psilocybin Therapy Amid National Psychedelic Research Surge
LOS ANGELES- In a groundbreaking move, Wisconsin lawmakers are pushing for enhanced access to psilocybin, a psychedelic compound found in magic mushrooms, for military veterans suffering from post-traumatic stress disorder (PTSD). This bipartisan bill represents ...
Irwin Naturals Inc. Reports Financial Performance in Q3 2023
LOS ANGELES- Irwin Naturals Inc, a key player in the cannabis and mental health sectors, recently disclosed its financial results for the third quarter of fiscal 2023, ending September 30, 2023. The report presents a complex ...
Maryland Supreme Court Refuses to Review Injunction on Anti-Intoxicating Hemp Law
LOS ANGELES- The Maryland Supreme Court has recently opted not to review a lower court's injunction against the enforcement of the state's law aimed at banning intoxicating hemp products. This decision, as detailed in a ...
Georgia Advances Medical Cannabis Program After Legal Delays
LOS ANGELES' In a significant development for Georgia's medical cannabis sector, state regulators have resumed the licensing process, concluding a prolonged two-year legal standoff. This move, as reported by the Valdosta Daily Times, comes after ...
Algernon Pharmaceuticals Partners with Seyltx Inc.
LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a significant advancement in its research program. The company has signed a Letter of Intent (LOI) with Seyltx Inc., a U.S.-based ...
Psychedelic Therapy for PTSD: Veterans Seek Healing in Mexico Amid U.S. Legal Restrictions
LOS ANGELES- A recent CBS News report has brought to light a significant trend among veterans dealing with PTSD: an increasing number are seeking psychedelic-assisted treatments in Mexico, utilizing substances currently deemed illegal by the ...
Optimi Health Obtains Key Amendment to Dealer’s Licence
LOS ANGELES- Optimi Health, a Canadian company specializing in psychedelic drug research and formulation, has achieved a significant milestone with Health Canada's approval of an amendment to its Dealer's Licence. This crucial development allows Optimi ...
Germany Amends Cannabis Legalization Bill, Balancing Reform and Regulation
BERLIN- German lawmakers have significantly revised the country's cannabis legalization bill, incorporating feedback from cannabis reform advocates and aiming for the bill's enactment in the upcoming spring. This development, as reported by Marijuana Moment, ...
Psyence Group Inc. Announces Resignation of Board Member Marvin Singer
LOS ANGELES- Psyence Group Inc a clinical-stage life science biotechnology firm at the forefront of utilizing nature-derived psilocybin for mental health and wellbeing, today announced the resignation of Mr. Marvin Singer from his role as ...
Compass Pathways Launches UK Phase of Landmark Psilocybin Study for Treatment-Resistant Depression
NEW YORK- Compass Pathways plc (Nasdaq: CMPS), a biotechnology leader dedicated to advancing mental health treatments, has announced the initiation of the UK component of its phase 3 program investigating COMP360 psilocybin treatment for treatment-resistant ...
Alabama Medical Cannabis Commission Settles Lawsuits
LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has made significant strides this week by reaching a settlement with license applicants, a move aimed at resolving the multiple lawsuits filed against the agency. This development, ...
Swedish Researchers Use Psychedelics to Explore Brain Function and AI Development
LOS ANGELES- In a groundbreaking study at Lund University in Sweden, researchers are employing psychedelic substances, specifically acid (LSD) and ketamine, to delve into the intricate workings of the brain. This unique approach aims to ...
Minnesota Tests New Saliva-Based Roadside Cannabis Impairment Assessment
LOS ANGELES- In a groundbreaking move, Minnesota's Office of Traffic Safety (OTS) has initiated a pilot program to test a saliva-based roadside cannabis impairment test. This innovative approach is designed to enhance the state's capabilities ...
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis dispensaries have achieved over $100 million in adult-use sales, ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development of innovative psychedelic treatments. The company announced the closure ...
Clearmind Medicine Inc. Announces Reverse Share Split to Comply with Nasdaq Regulations
NEW YORK- Clearmind Medicine Inc., a biotech company renowned for its innovative work in developing psychedelic-derived therapeutics, has announced a strategic decision to conduct a reverse share split of its ordinary shares. This move is ...
